Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspective.: DNA integrity of iPS cells

Qiang Bai 1, 2, 3 Romain Desprat 2 Bernard Klein 1, 2, 3 Jean-Marc Lemaitre 2, 4 John De Vos 5, 1, *
* Auteur correspondant
1 Cellules souches normales et cancéreuses
2 IRB - Institut de recherche en biothérapie
3 UM1 Médecine - Montpellier 1 - UFR de Médecine
4 IGF MGX - Institut de Génomique Fonctionnelle - Montpellier GenomiX
5 IBC - Institut de Biologie Computationnelle
Abstract : Induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs) are two types of pluripotent stem cells that hold great promise for biomedical research and medical applications. iPSCs were initially favorably compared to ESCs. This view was first based on ethical arguments (the generation of iPSCs does not require the destruction of an embryo) and on immunological reasons (it is easier to derive patient HLA-matched iPSCs than ESCs). However, several reports suggest that iPSCs might be characterized by higher occurrence of epigenetic and genetic aberrations than ESCs as a consequence of the reprogramming process. We focus here on the DNA integrity of pluripotent stem cells and examine the three main sources of genomic abnormalities in iPSCs: (1) genomic variety of the parental cells, (2) cell reprogramming, and (3) in vitro cell culture. Recent reports claim that it is possible to generate mouse or human iPSC lines with a mutation level similar to that of the parental cells, suggesting that "genome-friendly" reprogramming techniques can be developed. The issue of iPSC DNA integrity clearly highlights the crucial need of guidelines to define the acceptable level of genomic integrity of pluripotent stem cells for biomedical applications. We discuss here the main issues that such guidelines should address.
Keywords : Induced pluripotent stem cells cell reprogramming genetic abnormalities pluripotency DNA damage genome integrity
Type de document :
Article dans une revue
Current Gene Therapy, Bentham Science Publishers, 2013, 13 (2), pp.93-8
Liste complète des métadonnées

Littérature citée [41 références]  Voir  Masquer  Télécharger
http://www.hal.inserm.fr/inserm-00813131
Contributeur : Monique Frei <>
Soumis le : mardi 1 octobre 2013 - 07:00:15
Dernière modification le : vendredi 19 octobre 2018 - 19:30:08
Document(s) archivé(s) le : lundi 3 avril 2017 - 04:57:14

Fichiers

inserm-00813131_edited.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

  • HAL Id : inserm-00813131, version 1
  • PUBMED : 23317057

Collections

CIRAD | INRIA | IBC | INRA | UNIV-MONTPELLIER

Citation

Qiang Bai, Romain Desprat, Bernard Klein, Jean-Marc Lemaitre, John De Vos. Embryonic stem cells or induced pluripotent stem cells? A DNA integrity perspective.: DNA integrity of iPS cells. Current Gene Therapy, Bentham Science Publishers, 2013, 13 (2), pp.93-8. 〈inserm-00813131〉

Exporter

BibTeX TEI DC DCterms EndNote

Partager

Métriques

Consultations de la notice

520

Téléchargements de fichiers

602

Contact

support.ccsd.cnrs.fr
hal.support@ccsd.cnrs.fr
Logo CCSD